Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11054-11061
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11054
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11054
Figure 1 Speculative illustration.
Speculative illustration of expected hepatitis C virus (HCV)-RNA load and transaminase flare during and after rituximab cyclophosphamide, hydroxydaunorubicin, vincristine, prednisolone (R-CHOP) immmunochemotherapy for a diffuse large B-cell lymphoma ideal patient (not cirrhotic, no other risk factors) experiencing transient toxicity. Curves and histograms reflect the average behavior of patients reported so far in the literature.
- Citation: Visco C, Finotto S. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment. World J Gastroenterol 2014; 20(32): 11054-11061
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11054.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11054